NTLA (intelliatx.com) Volume dodolan mangsa ngarep perusahaan

Logo grafis Intellia Therapeutics Inc (NTLA)

Intellia Therapeutics (NTLA) leads the in vivo CRISPR editing segment as it awaits key trial results for NTLA-2001 and NTLA-2002. These developments are based on proprietary patents and support from US medical centers. The company's projected sales levels demonstrate forecast dynamics, where the value of 0.05 serves as the current metric. Environmental policy focuses on the safe disposal of chemicals and the rational use of laboratory resources.

NTLA - Pendapatan mangsa ngarep perusahaan Intellia Corp ing rentang 04.07.2022 - 17.11.2026

Rincian metrik keuangan lan pasar Intellia (NTLA)

Analisis komprehensif perusahaan:NTLA Intellia Therapeutics
Produk mawa merek Intellia Therapeutics Inc

Fundamental analysis of this indicator allows for risk minimization by assessing the ability of Intellia Therapeutics (NTLA) to monetize CRISPR genome-editing developments for amyloidosis therapy. This metric aggregates operational changes into projected revenue; therefore, the firm's planned sales level reflects the balance between market share expansion and the risk of excessive working capital freeze within the innovation pipeline.

Analisis pesaing Intellia Therapeutics

Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|RGEN - Volume dodolan mangsa ngarep perusahaan|RNA - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan RARE (Ultragenyx)|Volume dodolan mangsa ngarep perusahaan BEAM|Prakiraan volume dodolan Sarepta Corp|Prakiraan pendapatan perusahaan Twist Bioscience, Inc. (TWST)|Volume dodolan mangsa ngarep perusahaan 10x Genomics TXG|Stoke Therapeutics - Volume dodolan mangsa ngarep perusahaan|BioLife Solutions Inc (BLFS) - Volume dodolan sing dikarepake perusahaan|wavelifesciences.com - Prakiraan volume dodolan|Maze Therapeutics Corp (MAZE) - Volume dodolan mangsa ngarep perusahaan|SION: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PRME|Prakiraan pendapatan perusahaan Taysha Gene Therapies|Prakiraan pendapatan perusahaan QURE (uniQure)|Prakiraan pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Solid Biosciences SLDB|OCGN - Volume dodolan mangsa ngarep perusahaan|pacb.com - Prakiraan volume dodolan|Benitec (BNTC) - Volume dodolan mangsa ngarep perusahaan|DSGN: Prakiraan volume dodolan|RCKT - Dodolan mangsa ngarep perusahaan|FDMT: Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan LXEO (lexeotx.com)|Prakiraan pendapatan perusahaan Korro Bio Inc. (KRRO)|Prakiraan volume pendapatan perusahaan EDIT|Prakiraan volume dodolan SLN (Silence Therapeutics PLC)|Pendapatan mangsa ngarep perusahaan PRQR|CDXS - Prakiraan pendapatan perusahaan|SGMO (Sangamo Therapeutics) - Prakiraan pendapatan perusahaan|NAUT: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan MGX|DTIL (precisionbiosciences.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GBIO (Generation Bio Co.)|Prakiraan pendapatan perusahaan Boundless Bio (BOLD)|Exicure - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IMNN (imunon.com)|Dodolan mangsa ngarep perusahaan Phio Pharmaceuticals (PHIO)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan